Dan Luo

1.3k total citations
76 papers, 827 citations indexed

About

Dan Luo is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Dan Luo has authored 76 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 14 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Epidemiology. Recurrent topics in Dan Luo's work include Tuberculosis Research and Epidemiology (7 papers), Diabetes Management and Research (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Dan Luo is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Diabetes Management and Research (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Dan Luo collaborates with scholars based in China, United States and United Kingdom. Dan Luo's co-authors include Mingzi Li, Xue Cai, Yanhui Lu, Ruxue Li, Taihua Mu, Hongnan Sun, Huijing Zhang, Shanhu Qiu, Jie Huang and Guowei Fang and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Diabetes.

In The Last Decade

Dan Luo

66 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Luo China 18 177 144 130 123 108 76 827
Soleiman Kheiri Iran 19 100 0.6× 157 1.1× 94 0.7× 67 0.5× 118 1.1× 150 1.2k
Meseret Derbew Molla Ethiopia 16 99 0.6× 175 1.2× 95 0.7× 165 1.3× 113 1.0× 47 942
Hei‐Jen Jou Taiwan 18 121 0.7× 96 0.7× 67 0.5× 68 0.6× 88 0.8× 49 1.1k
Amy Hofman Netherlands 14 84 0.5× 161 1.1× 149 1.1× 172 1.4× 164 1.5× 34 1.0k
Mahdi Shadnoush Iran 21 136 0.8× 362 2.5× 214 1.6× 150 1.2× 108 1.0× 84 1.4k
Chi‐Hua Yen Taiwan 18 90 0.5× 315 2.2× 249 1.9× 187 1.5× 124 1.1× 43 1.3k
Mehdi Birjandi Iran 17 61 0.3× 128 0.9× 75 0.6× 46 0.4× 146 1.4× 97 990
Pallavi Dubey United States 14 105 0.6× 72 0.5× 147 1.1× 127 1.0× 84 0.8× 23 1.0k
Mi Jin Lee South Korea 17 54 0.3× 120 0.8× 47 0.4× 146 1.2× 98 0.9× 109 1.0k
Bruce Burnett United States 22 165 0.9× 421 2.9× 107 0.8× 112 0.9× 135 1.3× 60 1.5k

Countries citing papers authored by Dan Luo

Since Specialization
Citations

This map shows the geographic impact of Dan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Luo more than expected).

Fields of papers citing papers by Dan Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Luo. The network helps show where Dan Luo may publish in the future.

Co-authorship network of co-authors of Dan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Luo. A scholar is included among the top collaborators of Dan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Luo. Dan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Dan, et al.. (2025). The evaluation of Phenylalanine-tRNA ligase beta unit (PheT), as a potential target in Mycobacterium abscessus. Tuberculosis. 152. 102626–102626. 1 indexed citations
2.
Luo, Dan, Na Li, Xiaomin Peng, et al.. (2025). Identification and Pathogenicity Analysis of Feline Calicivirus in Shanghai and Guangdong, China. Transboundary and Emerging Diseases. 2025(1). 8729295–8729295.
4.
Wang, Wei, Yu Zhang, Qian Wu, et al.. (2025). Effect of population aging on pulmonary tuberculosis burden in Zhejiang Province, China: a population-based study. Frontiers in Public Health. 13. 1647139–1647139.
5.
Wang, Qian, Zhenzhen Sun, Le Sun, et al.. (2024). USP13 inhibition exacerbates mitochondrial dysfunction and acute kidney injury by acting on MCL-1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167599–167599.
6.
Hou, Lianhua, et al.. (2024). Effect of biochar-based nano‑nickel catalyst on heavy crude oil upgrading and oil shale pyrolysis. 195. 207011–207011. 3 indexed citations
7.
Zhang, Xueqing, Dan Luo, Jia‐Rui Shi, et al.. (2024). Predicting nursing workload in digestive wards based on machine learning: A prospective study. BMC Nursing. 23(1). 908–908. 4 indexed citations
8.
Luo, Dan, et al.. (2023). The role of family support in diabetes self‐management among rural adult patients. Journal of Clinical Nursing. 32(19-20). 7238–7246. 17 indexed citations
9.
Shen, Peng, Zongming Yang, Yexiang Sun, et al.. (2023). Association between visit-to-visit lipid variability and risk of ischemic heart disease: a cohort study in China. Endocrine. 84(3). 914–923. 2 indexed citations
10.
An, Kang, Ruohan Zhang, Liyun Liu, et al.. (2023). Familiarity of teaching skills among general practitioners transfer training trainers in China: a cross-sectional survey. BMC Medical Education. 23(1). 949–949. 3 indexed citations
11.
Zhou, Meng, et al.. (2023). The effect of diabetes mellitus on tuberculosis in eastern China: A decision‐tree analysis based on a real‐world study. Journal of Diabetes. 15(11). 920–930. 6 indexed citations
12.
Cui, Shengyu, et al.. (2022). Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation. SHILAP Revista de lepidopterología. 7 indexed citations
13.
Ye, Qing, Mei Wu, Chao Zhou, et al.. (2022). Rational development of a combined mRNA vaccine against COVID-19 and influenza. npj Vaccines. 7(1). 84–84. 33 indexed citations
14.
Zhang, Huijing, Qi Zhang, Dan Luo, et al.. (2021). The effect of family‐based intervention for adults with diabetes on HbA1c and other health‐related outcomes: Systematic review and meta‐analysis. Journal of Clinical Nursing. 31(11-12). 1488–1501. 15 indexed citations
15.
Zhang, Huijing, Dan Luo, Yanhui Lu, et al.. (2021). Growth and challenges of China's nursing workforce from 1998 to 2018: A retrospective data analysis. International Journal of Nursing Studies. 124. 104084–104084. 29 indexed citations
16.
Luo, Dan, Yong‐Qiang Deng, & Cheng‐Feng Qin. (2021). Current status of drug candidates against SARS-CoV-2. Jiefangjun yixue zazhi. 46(6). 628–633. 1 indexed citations
17.
Cai, Xue, Dan Luo, Shilin Liu, et al.. (2021). Four-year changes in central fatness, risk of diabetes, and metabolic control in older adults: a cohort study with mediation analysis. The Korean Journal of Internal Medicine. 37(1). 230–240. 4 indexed citations
18.
Xu, Yunsheng, et al.. (2020). Probe into the Target and Mechanism of Jianpi Xiaoke Prescription for Treating Type 2 Diabetes Mellitus through miRNA Expression Profiling. Evidence-based Complementary and Alternative Medicine. 2020(1). 7370350–7370350. 3 indexed citations
19.
Luo, Dan, et al.. (2017). Effect of nutritional supplement combined with exercise intervention on sarcopenia in the elderly: A meta-analysis. International Journal of Nursing Sciences. 4(4). 389–401. 29 indexed citations
20.
Zheng, Chaoyi, et al.. (2016). [Clinical analysis of two cases of imported children Zika virus infection in China].. PubMed. 54(5). 375–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026